NK
Nanda Kumar Parthasarathy
About Nanda Kumar Parthasarathy
Nanda Kumar Parthasarathy has 11 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Shatayuh Healthcare Llp and Shatayuh Jeevanam Healthcare India Private Limited. Formerly with 1 company, such as S2 Integrators Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Shatayuh Healthcare Llp
AAV-2025
|
Designated Partner | 22 Dec 2020 | 2020 | Active |
|
Shatayuh Jeevanam Healthcare India Private Limited
U26600TN2023PTC165069
|
Director | 08 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
S2 Integrators Private Limited
U72900TN2015PTC099014
|
Director | 29 Jan 2015 | 2015 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nanda Kumar Parthasarathy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanda Kumar Parthasarathy
Nanda Kumar Parthasarathy has 11 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Shatayuh Healthcare Llp and Shatayuh Jeevanam Healthcare India Private Limited. Formerly with 1 company, such as S2 Integrators Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Nanda Kumar Parthasarathy is associated with 2 companies as Designated Partner and Director.
Nanda Kumar Parthasarathy has expertise in Healthcare, General Business.
Nanda Kumar Parthasarathy has 11 years in corporate governance.